This review is briefly to recall the history of research and development (R&D) of Chinese materia medica (CMM) and to discuss the challenges of Chinese traditional and herbal medicines (CTHM) facing the modern science and technology. The R&D of CTHM is thought to be an important pathway for new drug discovery. Since1949, about 140 approved new drugs have been developed, among which about 80 originated directly or indirectly from medicinal plants. CTHM has gained interest from the international medical, biomedical, and pharmaceutical institutions as a valuable source of potential medicines. For the modernization of CMM and innovative research of CTHM, there are following challenges to be faced: (1) to evaluate the efficacy, pharmacological properties, action mechanism, and active chemical constituents; (2) to develop new methodologies for the quality and safety of CTHM; (3) to apply new “-omics” techniques to accelerate drug discoveries developed from CTHM; and (4) to apply international practices including good agricultural practice, good manufacturing practice, good laboratory practice, and good clinical practice in the R&D of CTHM.
LIU Chang-xiao, XIAO Pei-gen, PENG Yong, SONG Nai-ning. Challenges in Research and Development of Traditional Chinese Medicines[J]. Chinese Herbal Medicines (CHM),2009,1(1):1-28
LIU Chang-xiao, XIAO Pei-gen, PENG Yong, SONG Nai-ning. Challenges in Research and Development of Traditional Chinese Medicines[J]. Chinese Herbal Medicines (CHM),2009,1(1):1-28
LIU Chang-xiao, XIAO Pei-gen, PENG Yong, SONG Nai-ning. Challenges in Research and Development of Traditional Chinese Medicines[J]. Chinese Herbal Medicines (CHM),2009,1(1):1-28
LIU Chang-xiao, XIAO Pei-gen, PENG Yong, SONG Nai-ning. Challenges in Research and Development of Traditional Chinese Medicines[J]. Chinese Herbal Medicines (CHM),2009,1(1):1-28
LIU Chang-xiao, XIAO Pei-gen, PENG Yong, SONG Nai-ning. Challenges in Research and Development of Traditional Chinese Medicines[J]. Chinese Herbal Medicines (CHM),2009,1(1):1-28
[10]王康正,高文远,范磊,赵淑平,肖培根,傅荣昭.DNA分子诊断技术在药用植物研究上的应用[J].China Journal of Chinese Materia Medica,1997,22(12):707-709.
[11]胡亚洁,赵晓锦,宋咏梅,付先军.基于网络药理学的中药复方研究探讨[J].Lishizhen Medicine and Materia Medica Research,2018(6).
[12]Si-bao Chen, Yong Peng, Shi-lin Chen, Pei-gen Xiao.Introduction of Pharmaphylogeny[J].World Science and Technology(Modernization of Traditional Chinese Medicine),2005,7(6):97-103.
[13]Chen Sibao,Feng Yong,Chen Shilin and Xiao Peigen.Introduction of Pharmaphylogeny[J].World Science and Technology-Modernization of Traditional Chinese Medicine,2005,7(6):97-103.
LIU Chang-xiao, XIAO Pei-gen, PENG Yong, SONG Nai-ning. Challenges in Research and Development of Traditional Chinese Medicines[J]. Chinese Herbal Medicines (CHM),2009,1(1):1-28
LIU Chang-xiao, XIAO Pei-gen, PENG Yong, SONG Nai-ning. Challenges in Research and Development of Traditional Chinese Medicines[J]. Chinese Herbal Medicines (CHM),2009,1(1):1-28
LIU Chang-xiao, XIAO Pei-gen, PENG Yong, SONG Nai-ning. Challenges in Research and Development of Traditional Chinese Medicines[J]. Chinese Herbal Medicines (CHM),2009,1(1):1-28
LIU Chang-xiao, XIAO Pei-gen, PENG Yong, SONG Nai-ning. Challenges in Research and Development of Traditional Chinese Medicines[J]. Chinese Herbal Medicines (CHM),2009,1(1):1-28
